Surgery – Miscellaneous – Methods
Reexamination Certificate
2000-07-07
2002-07-09
McDermott, Corrine (Department: 1648)
Surgery
Miscellaneous
Methods
C607S106000
Reexamination Certificate
active
06415797
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to hyperthermic treatment of herpesviruses.
BACKGROUND OF THE INVENTION
Human herpesviruses cause many diseases such as chicken pox. Epstein-Barr virus, human cytomegalovirus, varicella-zoster virus, herpes simplex virus-1, or herpes simplex virus-2 are examples of human herpesviruses. Recent studies have identified human herpesvirus-8 (HHV-8) as the putative agent causing Kaposi's sarcoma (KS).
In order to infect tissues and cell of the body, viruses have developed many different ways to evade or deceive the immune system. The human herpesviruses use latency as a defense against the immune system. Latency is the ability to be inactive when conditions are not right for proliferation or growth. A key to defeating these viruses is to force them into an active proliferation at a time when conditions are wrong.
Current treatments for human herpesviruses include aciclovir, cidofovir, famciclovir, doxorubicin and other pharmaceuticals. However, because these treatments are not effective for all patients, improved methods for treating human herpesviruses are being sought.
SUMMARY OF THE INVENTION
The invention provides a method for treating a patient infected with a human herpesvirus comprising raising the core temperature of the patient and then returning the core temperature of the patient to normal at least one time. The core temperature is raised to a temperature range, a duration, and a number of times sufficient to reduce or eliminate the patient's viral load of the human herpesvirus.
It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the invention as claimed.
REFERENCES:
patent: 4298006 (1981-11-01), Parks
patent: 5391142 (1995-02-01), Sites et al.
patent: 5674190 (1997-10-01), Kelly
patent: 5730720 (1998-03-01), Sites et al.
Lauritsen, J. “They Left Their HIV in San Francisco-A Report On The Sixth International Conference On AIDS” New York Native Jun. 24, 1990.*
Alonso et al., “Whole-Body Hyperthermia and the Augmentation of Cellular Cytotoxic Responses in the Treatment of Acquired Immune Deficiency Syndrome,”Southern Medical Journal, 88(10):S142 (1995).
Alonso et al., “Systemic Hyperthermia in the Treatment of HIV-related Disseminated Kaposi's Sarcoma,”Am. J. Clin. Oncol.(CCT), 17(4):353-359 (1994).
Alonso et al., “Systemic Hyperthermia in the Treatment of HIV-related Disseminated Malignancy. Long-Term Follow-Up of Patients Treated with High Flow or Low Flow Extracorporeal Perfusion Hyperthermia,” approximate date 1992 (18 pages).
Alonso et al., “Systemic Hyperthermia in the Treatment of HIV-related Kaposi's Sarcoma. A Phase I Study,”Biomed&Pharmacother,46(1):21-24 (1992).
“Backgrounder—Summary of Findings, Site Visit Report-Clinical Use of Hyperthermia in AIDS,” National Institute of Allergy and Infectious Diseases, Sep. 4, 1990 ( 5 pages).
“Extracorporeal Whole Body Hyperthermia as a ‘Salvage’ Therapy in the Treatment of Patients with HIV/AIDS,” First Circle Medical, Inc., 1999 (5 pages).
“Extracorporeal Whole Body Hyperthermia,” First Circle Medical, Inc., Doc. No. 1600002, 1999 (71 pages).
Feb. 25, 1994 Letter from the Department of Health and Human Services forwarding the “Full Report of the Site Visit Report—Clinical Use of Hyperthermia in AIDS” (24 pages, including cover letter).
Logan et al., “Case Report, Total Body Hyperthermia in the Treatment of Kaposi's Sarcoma in an HIV Positive Patient,”Med. Oncol.&Tumor Pharmacother, 8(1):45-47 (1991).
More, “Hyperthermia Finds Little Effect,”GMHC Treatment Issues,vol. 9, No. 11, Nov. 1995 (2 pages).
Olsen et al., “Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV8) and the Etiology of KS,” in Medveczky et al., eds.,Herpesviruses and Immunity, Plenum Publishing Corp., New York, New York, 1998, Chapter 5, pp. 115 to 117, and Tables I and II (11 pages total).
Pontiggia et al., “Therapeutic Hyperthermia in Cancer and AIDS: An Updated Survey,”J. Environ. Pathol. Toxicol. Oncol.,15(2-4):289-297 (1996) (abstract only).
Pontiggia et al., “Whole Body Hyperthermia Associated with Betacarotene Supplementation in Patients with AIDS,”Biomed&Pharmacother,5:263-265 (1995).
Pontiggia et al., “Whole-Body Hyperthermia Followed by Beta Carotene Supplementation in Patients with Acquired Immune Deficiency Syndrome (AIDS),”Southern Medical Journal,88(10):S142 (1995).
Reuters Medical News, “Evidence Found for Parallel HIV-1 and HHV-8 Epidemics in Homosexual Men in US,” Oct. 14, 1999 (2 pages) (referencesJ. Infect. Dis.,180:1010-1017 (1999)).
Shecterle et al., “Hyperthermia Alters HIV Kinetics,”Alternative Therapies in Clinical Practice, pp. 162-164 (Sep./Oct. 1997).
Shecterle et al., “More on Hepatitis C”The Scientist, May 24, 1999.
Spire et al., “Inactivation of Lymphadenopathy-Associated Virus By Heat, Gamma Rays, and Ultraviolet Light,”The Lancet,pp. 188-189 (Jan. 26, 1985).
Wong et al., “Tumor Necrosis Factor &agr; Selectively Sensitizes Human Immunodeficiency Virus-Infected Cells to Heat and Radiation,”Proc. Natl. Acad. Sci. USA, 88:4372-4376 (May 1991).
Yatvin, “An Approach to AIDS Therapy Using Hyperthermia and Membrane Modification,”Medical Hypotheses, 27:163-165 (1988).
Yatvin et al., “Shedding Light on the Use of Heat to Treat HIV Infections,”Oncology, 50:380-389 (1993).
Zablow et al., “Extracorporeal Whole Body Hyperthermia Treatment of HIV Patients, a Feasibility Study,”Int. J. Hyperthermia,13(6):577-586 (Nov.-Dec. 1997) (abstract only).
Blick Gary
Groth Karl Emil
Kelly Theodore Charles
Westerbeck Todd L.
Barrett Thomas C.
First Circle Medical, Inc.
McDermott Corrine
Popovich & Wiles, P.A.
LandOfFree
Treatment of human herpesviruses using hyperthermia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of human herpesviruses using hyperthermia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of human herpesviruses using hyperthermia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2830265